Difficulty: Medium
Average Score: 79%
Practice
Which of the following is an indication for starting surfactant therapy in a newborn?
Correct answer
B
Rationale
In a newborn with respiratory distress, the correct indication for starting surfactant therapy is an oxygen requirement greater than 40% for the first 6 hours of life (Option B). Surfactant therapy is indicated in preterm infants with respiratory distress syndrome (RDS) who have significant oxygenation impairment despite conventional respiratory support.
Option A, persistent respiratory acidosis despite ventilation, may indicate the need for respiratory support but not specifically surfactant therapy. Option C, frequent episodes of apnea, could suggest a need for respiratory support but not a direct indication for surfactant therapy. Option D, signs of meconium aspiration syndrome, would require supportive care and possibly respiratory interventions but not necessarily surfactant therapy.
Educationally, understanding the indications for surfactant therapy in newborns is crucial for pediatric nurses caring for infants with respiratory distress. It is essential to differentiate between various respiratory conditions and interventions to provide optimal care and improve outcomes for these vulnerable patients. Early recognition of the need for surfactant therapy can significantly impact the management and prognosis of newborns with respiratory distress syndrome.
Option A, persistent respiratory acidosis despite ventilation, may indicate the need for respiratory support but not specifically surfactant therapy. Option C, frequent episodes of apnea, could suggest a need for respiratory support but not a direct indication for surfactant therapy. Option D, signs of meconium aspiration syndrome, would require supportive care and possibly respiratory interventions but not necessarily surfactant therapy.
Educationally, understanding the indications for surfactant therapy in newborns is crucial for pediatric nurses caring for infants with respiratory distress. It is essential to differentiate between various respiratory conditions and interventions to provide optimal care and improve outcomes for these vulnerable patients. Early recognition of the need for surfactant therapy can significantly impact the management and prognosis of newborns with respiratory distress syndrome.